Viva Biotech Holdings (VBIZF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Viva Biotech Holdings's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
16.36
Strong
WeakModerateStrong
P/B Ratio
0.99
Strong
WeakModerateStrong
Earnings Yield
5.57%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
5.50%
Weak
WeakModerateStrong
Operating Margin
11.17%
Moderate
WeakModerateStrong
Net Profit Margin
12.71%
Moderate
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-15.19%
Weak
WeakModerateStrong
Net Income Growth
27.97%
Strong
WeakModerateStrong
EPS Growth
27.71%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.50
Moderate
WeakModerateStrong
Quick Ratio
1.26
Moderate
WeakModerateStrong
Asset Turnover
0.24x
Weak
WeakModerateStrong
Inventory Turnover
3.20x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.23%
Weak
WeakModerateStrong
EV / Free Cash Flow
47.37x
Weak
WeakModerateStrong
Net Debt / EBITDA
0.58x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.646
Strong
WeakModerateStrong
Return on Invested Capital
2.42%
Weak
WeakModerateStrong
Cash Conversion Cycle
174.96 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for VBIZF.
View Financial Statements